Addressing the Opioid Epidemic.

作者: Lewis S. Nelson , David N. Juurlink , Jeanmarie Perrone

DOI: 10.1001/JAMA.2015.12397

关键词:

摘要: Afteralcohol intoxication,opioidsare themostcommoncause ofpoisoninginpatientspresentingtoNorthAmericanemergency departments.1Mostopioidsmisusedbypatientsoriginate from prescriptionmedication.Most patientswhooverdoseonprescription opioids are taking their medications differently thanprescribedorareusingopioidsprescribedtosomeoneelse. These2main typesofnonmedical opioiduse representamajor causeofmorbidityandmortality.Someindividualswhomisuse opioidsareseekingeuphoriceffects,butothershavedeveloped dependence through chronic opioid use and simply trying toavoidopioidwithdrawal.Opioid-relatedharmhasnowreached epidemic levels: emergency department visits for nonmedical useofprescriptionopioidsmorethandoubledfrom2004to2011, accountingforanestimated488 000visits in2011.1Deathshave more than tripled since 1999, with an estimated 16 235 deaths attributable to prescription in 2013.2,3 In this issueof JAMA, the studybyHanet al4 examined current scopeof theopioidepidemic theUnitedStates.Using datafromnearlyhalfamillionrespondentstotheannualNational SurveyonDrugUseandHealth(NSDUH), theauthors foundthat overalltrendsinself-reportednonmedicaluseofprescriptionopioidsdecreasedfrom5.4%to4.9%overan11-yearperiod, includingadecline innewusersofopioids, from1%in2003to0.6%in 2013.Althoughthisoverall findingofa reduction innonmedical useofprescriptionopioidsisencouraging,thestudyalsoreported increases theprevalenceofprescriptionopioidusedisorders (abuseandaddiction)and theprevalenceofopioidassociatedmortality,usingdatafromtheNationalVitalStatistics System’sMultipleCauseofDeathFiles.Theauthorsalsoreported increasedprevalenceof frequentopioiduse (>100days/year) highly frequent (>200 days/year), as well a greater prevalenceofprescriptionopioidusedisorders inpatientswith majordepressiveepisodes(MDEs)thaninpatientswithoutthem. The findings ofHan et al suggest thatmore patients experiencing inexorable progression initial use, or disorder. Another report issue of JAMA by Saloner Karthikeyanaddressedarelatedquestion:Dopatientswithnonmedical access treatment?5 Among individuals identifiedinNSDUHashavinganopioidusedisorder, utilization substance abuse treatment during sameperiodasHanetal (2004-2013).Adjustedratesof individualswith disorders receiving treatmentwere lowand essentiallyunchangedduringthereportingperiod(18.8%in20042008to19.7%in2009-2013).SalonerandKarthikeyanalsofound thatthenumberofsettingsvisitedfortreatment(ie, inpatientservices,outpatientclinics,physicians’offices) increased, from2.8 to3.3, includingreceiptoftreatmentinofficesettings(from25.1% to34.8%)whereuseofbuprenorphineismost likely.Theauthors cannot explain why so many apparently did not seek treatment, suchaswhether it isnot available,not affordable, notof interest.Furthermore, theoutcomesof treatmentcannot bemeasuredwiththesedata,butotherstudieshavereportedthat long-termeffectiveness ofmost such therapies ismodest.6 Karthikeyan also found that over time, survey respondents were older less likely have private health insurance. Despite Mental Health Parity Addiction Equity Act 2008,7 which mandated insurersoffermentalhealthandaddictionbenefits comparablewith medical-surgical benefits, increase opportunitieswasnot observed latter part studyperiod, after act was implemented. This suggests ability topaymost likelywasnot theprimary factor thedecision forgo but does clarify roles to, interest in, Prescribingofopioidanalgesics,particularlyforchronicpain, appears be amain themajority use. Basedonotherdataavailable theNSDUH,prescribersare,directlyor indirectly, sourceofmostmisusedopioids.8Anestimated53%ofnonmedicalusersreportedobtainingprescription opioidsfromafriendorrelative,81%ofwhomreceivedtheirdrug fromaphysician. It isunclearwhether theseprescriptionswere issuedfortherapeuticpurposesororiginatedfromunscrupulous prescribers (ie, “pillmills”); regardless, sourceofopioiduse andmisuse is often seemingly legitimate prescription. There little evidence long-term benefit therapy formost typesof chronicpain.9 remainsunclearwhy thispracticeofopioidprescribingcontinuesdespite recommendationstothecontrary.9,10Newopioidmedications,manyofthem withtamper-resistantformulations,continuetobemarketeddespite lackofevidencethat thesepreparationsreducetherisk ofaddiction.11More than10%ofpatientswho initiate withopioidswill likelyprogress tochronicuse,definedasongoingtreatmentformorethan3months.12Nearlyallpatientstreated withlong-termopioidtherapydeveloptoleranceanddependence tovaryingdegrees,about25%becomenonmedicalusers,and10% developfeaturessuggestiveofaddiction.13Thesearesoberingpercentagesinlightofthemillionsofpatientsprescribedthesedrugs everyyear.14Consequently,forthemanypatientswhoneedtreatment addictionor complicationsof substancemisuse, there areoftensignificantbarriers toobtainingcare.6Dependence,addiction, anddose escalation resulting tolerancemakediscontinuingopioidsdifficult.Manypatientsunderstandablyperceivetheyneedongoingopioidanalgesic therapybecause,when thedrugsarediscontinued,anunpleasantwithdrawalsyndrome withassociatedpainensues.Patientsquickly learnthat resumpRelated articles pages 1468 1515 Opinion

参考文章(13)
Margaret A. Honein, Cheryl S. Broussard, Meghan T. Frey, Jennifer N. Lind, April L. Dawson, Elizabeth C. Ailes, Suzanne M. Gilboa, Opioid prescription claims among women of reproductive age--United States, 2008-2012. Morbidity and Mortality Weekly Report. ,vol. 64, pp. 37- 41 ,(2015)
Pamela Leece, Aaron M. Orkin, Meldon Kahan, Tamper-resistant drugs cannot solve the opioid crisis Canadian Medical Association Journal. ,vol. 187, pp. 717- 718 ,(2015) , 10.1503/CMAJ.150329
Lainie Rutkow, Hsien-Yen Chang, Matthew Daubresse, Daniel W. Webster, Elizabeth A. Stuart, G. Caleb Alexander, Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use JAMA Internal Medicine. ,vol. 175, pp. 1642- 1649 ,(2015) , 10.1001/JAMAINTERNMED.2015.3931
Beth Han, Wilson M. Compton, Christopher M. Jones, Rong Cai, Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013 JAMA. ,vol. 314, pp. 1468- 1478 ,(2015) , 10.1001/JAMA.2015.11859
Roger Chou, Judith A. Turner, Emily B. Devine, Ryan N. Hansen, Sean D. Sullivan, Ian Blazina, Tracy Dana, Christina Bougatsos, Richard A. Deyo, The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop Annals of Internal Medicine. ,vol. 162, pp. 276- 286 ,(2015) , 10.7326/M14-2559
Jeanmarie Perrone, Lewis S. Nelson, Donald M. Yealy, Choosing Analgesics Wisely: What We Know (and Still Need to Know) About Long-Term Consequences of Opioids. Annals of Emergency Medicine. ,vol. 65, pp. 500- 502 ,(2015) , 10.1016/J.ANNEMERGMED.2015.01.021
Kevin E. Vowles, Mindy L. McEntee, Peter Siyahhan Julnes, Tessa Frohe, John P. Ney, David N. van der Goes, Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. ,vol. 156, pp. 569- 576 ,(2015) , 10.1097/01.J.PAIN.0000460357.01998.F1
Theodore J. Cicero, Matthew S. Ellis, Hilary L. Surratt, Steven P. Kurtz, The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years JAMA Psychiatry. ,vol. 71, pp. 821- 826 ,(2014) , 10.1001/JAMAPSYCHIATRY.2014.366
Andrew Kolodny, David T. Courtwright, Catherine S. Hwang, Peter Kreiner, John L. Eadie, Thomas W. Clark, G. Caleb Alexander, The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction Annual Review of Public Health. ,vol. 36, pp. 559- 574 ,(2015) , 10.1146/ANNUREV-PUBLHEALTH-031914-122957